NYSEAMERICAN:NSPR InspireMD Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding InspireMD Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.34 -0.01 (-2.89 %) (As of 09/22/2020 12:00 AM ET) Add Compare Share Today's Range$0.32Now: $0.34▼$0.3450-Day Range N/A52-Week Range$0.32Now: $0.34▼$1.64Volume613,784 shsAverage Volume1.99 million shsMarket Capitalization$11.19 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingInspireMD has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $2.00, InspireMD has a forecasted upside of 496.1% from its current price of $0.34.Amount of Analyst CoverageInspireMD has received no research coverage in the past 90 days. Previous Next 2.6 Community Rank Outperform VotesInspireMD has received 191 “outperform” votes. (Add your “outperform” vote.)Underperform VotesInspireMD has received 183 “underperform” votes. (Add your “underperform” vote.)Community SentimentInspireMD has received 51.07% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about InspireMD and other stocks. Vote “Outperform” if you believe NSPR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NSPR will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldInspireMD does not currently pay a dividend.Dividend GrowthInspireMD does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, InspireMD insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.22 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSEAMERICAN Industry Medical Appliances & Equipment Sub-IndustryN/A SectorMedical Current SymbolNYSEAMERICAN:NSPR Previous SymbolNASDAQ:NSPR CUSIPN/A CIK1433607 Webwww.inspiremd.com Phone+1-857-4536553Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees43 Outstanding Shares33,358,000Market Cap$11.19 million Next Earnings Date11/10/2020 (Estimated) OptionableNot Optionable $0.34 -0.01 (-2.89 %) (As of 09/22/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive NSPR News and Ratings via Email Sign-up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter. InspireMD (NYSEAMERICAN:NSPR) Frequently Asked Questions Do Wall Street analysts recommend investors buy shares of InspireMD? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InspireMD in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for InspireMD. When is InspireMD's next earnings date? InspireMD is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020. View our earnings forecast for InspireMD. How were InspireMD's earnings last quarter? InspireMD Inc (NYSEAMERICAN:NSPR) issued its earnings results on Wednesday, August, 5th. The medical equipment provider reported ($0.20) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.35) by $0.15. The medical equipment provider had revenue of $0.31 million for the quarter, compared to analysts' expectations of $0.20 million. View InspireMD's earnings history. When did InspireMD's stock split? How did InspireMD's stock split work? InspireMD shares reverse split on Monday, April 1st 2019. The 1-50 reverse split was announced on Tuesday, March 26th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, March 29th 2019. An investor that had 100 shares of InspireMD stock prior to the reverse split would have 2 shares after the split. What price target have analysts set for NSPR? 1 analysts have issued 1-year price objectives for InspireMD's stock. Their forecasts range from $2.00 to $2.00. On average, they expect InspireMD's stock price to reach $2.00 in the next twelve months. This suggests a possible upside of 496.1% from the stock's current price. View analysts' price targets for InspireMD. Are investors shorting InspireMD? InspireMD saw a increase in short interest in August. As of August 31st, there was short interest totaling 246,100 shares, an increase of 18.7% from the August 15th total of 207,300 shares. Based on an average trading volume of 3,680,000 shares, the short-interest ratio is presently 0.1 days. View InspireMD's Short Interest. Who are some of InspireMD's key competitors? Some companies that are related to InspireMD include Intelligent Ultrasound Group (MED), LiDCO Group (LID), Deltex Medical Group (DEMG), Zecotek Photonics (ZMS), Lucid (LCDX), MCP Income Opp Trust Ordinary Units FP (MOT) and Verisante Technology (VRS). View all competitors. What other stocks do shareholders of InspireMD own? Based on aggregate information from My MarketBeat watchlists, some companies that other InspireMD investors own include Biocept (BIOC), Palatin Technologies (PTN), TransEnterix (TRXC), Catalyst Pharmaceuticals (CPRX), Inovio Pharmaceuticals (INO), Curis (CRIS), Ibio (IBIO), Inpixon (INPX), Novavax (NVAX) and Rewalk Robotics (RWLK). Who are InspireMD's key executives? InspireMD's management team includes the following people: Dr. James J. Barry, Pres, CEO & Director (Age 60)Mr. Craig Shore, CFO, Chief Admin. Officer, Sec. & Treasurer (Age 58)Mr. Agustin V. Gago, Exec. VP & Chief Commercial Officer (Age 59)Mr. Roei Samuri, VP of OperationsDr. Sol J. Barer, Special Advisor to the Board (Age 72) What is InspireMD's stock symbol? InspireMD trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NSPR." Who are InspireMD's major shareholders? InspireMD's stock is owned by many different retail and institutional investors. Top institutional shareholders include Wedbush Securities Inc. (2.78%). Company insiders that own InspireMD stock include Paul Stuka and Thomas J Kester. View institutional ownership trends for InspireMD. Which major investors are buying InspireMD stock? NSPR stock was purchased by a variety of institutional investors in the last quarter, including Wedbush Securities Inc.. View insider buying and selling activity for InspireMD. How do I buy shares of InspireMD? Shares of NSPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is InspireMD's stock price today? One share of NSPR stock can currently be purchased for approximately $0.34. How big of a company is InspireMD? InspireMD has a market capitalization of $11.19 million. InspireMD employs 43 workers across the globe. What is InspireMD's official website? The official website for InspireMD is www.inspiremd.com. How can I contact InspireMD? InspireMD's mailing address is 4 Menorat Hamaor St., TEL AVIV-YAFO, MA 6744832, Israel. The medical equipment provider can be reached via phone at +1-857-4536553. This page was last updated on 9/23/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
